摘要
近年来,我国药物临床试验机构越来越多地参与到国际多中心临床试验(IMCT)中来。本文综述了IMCT在国内的发展概况,剖析了中国在开展IMCT中面临的机遇及出现的问题,并提出相应的建议和措施。
In recent years,more and more Chinese clinical research institutions took part in the international multicenter clinical trials( IMCT).This article will review the development of IMCT in China,and analyze the opportunities and challenges that IMTC development in China faced,and put forward corresponding suggestions and measures.
作者
冀希炜
吕媛
JI Xi-wei;Lu Yuan(Institute of Clinical Pharmacology,Peking University First Hospital,Beijing 100191,China)
出处
《中国临床药理学杂志》
CAS
CSCD
北大核心
2019年第4期399-401,408,共4页
The Chinese Journal of Clinical Pharmacology
关键词
国际多中心临床试验
挑战
机遇
international multicenter clinical trial
challenge
opportunity
